These include glutamine synthetase (GLUL), α-methylacyl-CoA racemase (AMACR, associated with CTNNB1 mutations in HCC44), ACSS3 (ACSS3, associated with a metabolic HCC subclass characterized by frequent CTNNB1 mutations10). The gene discussed is GLUL; the disease is hepatocellular carcinoma.